Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Ross A. Baker - Atypical Antipsychotic Drugs and Diabetes Mellitus in the US Food and Drug Administration Adverse Event Database: A Systematic Bayesian Signal Detection Analysis
1
x
$
30.00
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
1
x
$
30.00
Paroxetine versus Vortioxetine for Depressive Symptoms in Postmenopausal Transition: A Preliminary Study
1
x
$
30.00
Bereavement During a Course of TMS for MDD: A Case Report
1
x
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
1
x
$
30.00
Jeffrey E. Kelsey, MD, PhD: Social Anxiety: An Often Silent Disorder
1
x
$
30.00
Efficacy and Tolerability of Two Different Kinds of Titration of Paroxetine Hydrocloride Solution: an Observational Study
1
x
$
30.00
C. Lindsay DeVane, PharmD: Psychoactive Drug Interactions With Pharmacotherapy for Diabetes
1
x
$
30.00
View Cart
Checkout
Home
pathophysiology
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Haim Einat, PhD: New Approaches to Modeling Bipolar Disorder
$
30.00
Add to cart
Details
Alexander Neumeister, MD: Tryptophan Depletion, Serotonin, and Depression: Where Do We Stand?
$
30.00
Add to cart
Details
Paul A. Cannistraro, MD: Neural Circuitry of Anxiety: Evidence from Structural and Functional Neuroimaging Studies
$
30.00
Add to cart
Details
C. Philip O’Carroll, MD: Migraine And The Limbic System: Closing The Circle
$
30.00
Add to cart
Details
In Vivo Neuroimaging Correlates of the Efficacy of Paroxetine in the Treatment of Mood and Anxiety Disorders
$
30.00
Add to cart
Details
Page load link
Go to Top
